Healthcare Professional Resources

Click here to download the TALZENNA Patient Booklet

Click here to download the TALZENNA HCP Therapy Management Booklet

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BRCA=breast cancer susceptibility gene; CI=confidence interval; HER2-=human epidermal growth factor receptor 2 negative; HR=hazard ratio.

 

REFERENCES
  1. TALZENNA Summary of Product Characteristics.
  2. Gavande NS, VanderVere-Carozza PS, Hinshaw HD, et al. DNA repair targeted therapy: the past or future of cancer treatment? Pharmacol Ther. 2016;160:65-83.
 

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of full SmPC for how to report adverse reactions.